595 results on '"Tirumani, Sree Harsha"'
Search Results
102. Ipilimumab associated hepatitis: imaging and clinicopathologic findings
103. Current concepts in the imaging of uterine sarcoma
104. Impact of BRAF mutations on outcomes in metastatic melanoma with central nervous system metastases treated with immune checkpoint inhibitors.
105. Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional Imaging Findings
106. Role of Key Guidelines in an Era of Precision Oncology: A Primer for the Radiologist
107. Cancer Clinical Trials: What Every Radiologist Wants to Know but Is Afraid to Ask
108. Definition, Incidence, and Challenges for Assessment of Hyperprogressive Disease During Cancer Treatment With Immune Checkpoint Inhibitors
109. Gas Where It Shouldn't Be! Imaging Spectrum of Emphysematous Infections in the Abdomen and Pelvis
110. Distal intestinal obstruction syndrome: a mimic of acute appendicitis
111. Comparison of RECIST 1.1 and iRECIST in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
112. A novel imaging based Nomogram for predicting post-surgical biochemical recurrence and adverse pathology of prostate cancer from pre-operative bi-parametric MRI
113. Spalding sign
114. COVID-19 Pandemic Impact on Decreased Imaging Utilization: A Single Institutional Experience
115. The Role of Imaging and Systemic Treatments in Myeloma: A Primer for Radiologists
116. Utilization of imaging in pancreatic adenocarcinoma patients status post Whipple procedure.
117. Evaluation of equivocal small cystic pancreatic lesions with spectral-detector computed tomography
118. Optimization of timing of hepatocellular phase imaging after gadoxetate disodium injection for evaluation of patients with neuroendocrine tumor
119. PD57-05 A DEEP LEARNING NETWORK ALONG WITH PIRADS CAN DISTINGUISH CLINICALLY SIGNIFICANT AND INSIGNIFICANT PROSTATE CANCER ON BI-PARAMETRIC MRI
120. MP81-06 RADIOMIC FEATURES OF PROSTATE CANCER PATIENTS (GLEASON GRADE GROUP = 2) SHOW DIFFERENCES BETWEEN AFRICAN AMERICAN AND CAUCASIAN POPULATIONS ON BI-PARAMETRIC MRI
121. Radiomic features derived from periprostatic fat on pre-surgical T2w MRI predict extraprostatic extension of prostate cancer identified on post-surgical pathology: preliminary results
122. Hemophagocytic Lymphohistiocytosis: A Primer for Radiologists
123. Imaging and clinical manifestations of immune checkpoint inhibitor-related colitis in cancer patients treated with monotherapy or combination therapy
124. Evaluating the sensitivity of deep learning to inter-reader variations in lesion delineations on bi-parametric MRI in identifying clinically significant prostate cancer
125. Overview of imaging findings associated with systemic therapies in advanced epithelial ovarian cancer
126. Tumor Response Criteria in Oncoimaging: RECIST Criteria and beyond—Part 2
127. Tumor Response Criteria in Oncoimaging: RECIST Criteria and beyond—Part 1
128. Focal Liver Uptake on FDG PET/CT Without CT Correlate: Utility of MRI in the Evaluation of Patients With Known Malignancy
129. An update on Burkitt lymphoma: a review of pathogenesis and multimodality imaging assessment of disease presentation, treatment response, and recurrence
130. CPI Adult Cancer Imaging Special Edition Module
131. What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms?
132. Evaluation of equivocal small cystic pancreatic lesions with spectral-detector computed tomography.
133. Solitary Extramedullary Multiple Myeloma Presenting with Small Bowel Obstruction
134. Hallmarks of Cancer in the Reading Room: A Guide for Radiologists
135. Lobular breast cancer: patterns of intraabdominal metastatic spread on imaging and prognostic significance
136. Shear Wave Elastography as a Quantitative Biomarker of Clinically Significant Portal Hypertension: A Systematic Review and Meta-Analysis
137. Gastroenteropancreatic neuroendocrine tumors: impact of consistent contrast agent selection on radiologists’ confidence in hepatic lesion assessment on restaging MRIs
138. Metastatic Patterns of Solitary Fibrous Tumors: A Single-Institution Experience
139. Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful
140. Patterns and Prognostic Importance of Hepatic Involvement in Patients with Serous Ovarian Cancer: A Single-Institution Experience with 244 Patients
141. Update on Gastrointestinal Stromal Tumors for Radiologists
142. Current Concepts in Non-Gastrointestinal Stromal Tumor Soft Tissue Sarcomas: A Primer for Radiologists
143. Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know
144. MRI Findings in Patients With Leukemia and Positive CSF Cytology: A Single-Institution 5-Year Experience
145. Radiomic features derived from periprostatic fat on pre-surgical T2w MRI predict extraprostatic extension of prostate cancer identified on post-surgical pathology: preliminary results
146. What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms?
147. Diffusion-weighted MR imaging of mucin-rich mucinous tubular and spindle cell carcinoma of the kidney: a case report
148. Sunitinib-associated Pancreatic Atrophy in Patients with Gastrointestinal Stromal Tumor: A Toxicity with Prognostic Implications Detected at Imaging
149. Beyond gastric adenocarcinoma: Multimodality assessment of common and uncommon gastric neoplasms
150. Current Concepts in the Molecular Genetics and Management of Thyroid Cancer: An Update for Radiologists
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.